ETFs that hold Simcere Pharmaceutical Group Ltd

20 thematic and core ETFs hold Simcere Pharmaceutical Group Ltd, by holdings dated Jun 30, 2026 to Nov 19, 2026. ECNS holds the most, at 0.82% of the fund on Nov 19, 2026. The next largest are AVEE (0.13%) and CXSE (0.11%).

Funds holding it
20in the diversified set
Largest holder
ECNS0.82% of the fund
Total ETF ownership
$52mweights x net assets, all 20 funds
Change since last run
−$511k20 funds on 2026-11-19, 20 now
The answer

Which ETFs hold the most

ECNSiShares MSCI China Small-Cap ETF
0.82%
AVEEAvantis Emerging Markets Small Cap Equity ETF
0.13%
CXSEWisdomTree China ex-State-Owned Enterprises Fund
0.11%
AVESAvantis Emerging Markets Value ETF
0.08%
EEMSiShares MSCI Emerging Markets Small-Cap ETF
0.08%
EMGFiShares Emerging Markets Equity Factor ETF
0.08%
GXCState Street SPDR S&P China ETF
0.05%
AVEMAvantis Emerging Markets Equity ETF
0.04%
More

0 funds above 10%, 0.02% median share, 20 funds under 1%

Share of each fund held in Simcere Pharmaceutical Group Ltd, as of Nov 21, 2026.

Share
The evidence
Hypothetical · drag your weights

How much of this company do my ETFs hold?

Hypothetical. With this mix, 0.5% of your money is in Simcere Pharmaceutical Group Ltd, held through ECNS, AVEE, CXSE.

The data

Thematic and core funds that hold it

Open the full table
1ECNSiShares MSCI China Small-Cap ETF0.82%Nov 19, 2026Equity
2AVEEAvantis Emerging Markets Small Cap Equity ETF0.13%Nov 17, 2026Equity
3CXSEWisdomTree China ex-State-Owned Enterprises Fund0.11%Jun 30, 2026Equity
4AVESAvantis Emerging Markets Value ETF0.08%Nov 17, 2026Equity
5EEMSiShares MSCI Emerging Markets Small-Cap ETF0.08%Nov 19, 2026Equity
6EMGFiShares Emerging Markets Equity Factor ETF0.08%Nov 19, 2026Equity
7GXCState Street SPDR S&P China ETF0.05%Nov 19, 2026Equity
8AVEMAvantis Emerging Markets Equity ETF0.04%Nov 17, 2026Equity
9DFSEDimensional Emerging Markets Sustainability Core 1 ETF0.03%Jul 31, 2026Equity
10VSSVanguard FTSE All-Wld ex-US SmCp Idx ETF0.03%Oct 31, 2026Equity
11GLOFiShares Global Equity Factor ETF0.02%Nov 19, 2026Equity
12DFEMDimensional Emerging Markets Core Equity 2 ETF0.01%Jul 31, 2026Equity
13DFAEDimensional Emerging Core Equity Market ETF0.01%Jul 31, 2026Equity
14IEMGiShares Core MSCI Emerging Markets ETF0.01%Nov 19, 2026Equity
15VWOVanguard FTSE Emerging Markets ETF0.01%Oct 31, 2026Equity
16TLTENorthern Trust Morningstar Emerging Markets Factor Tilt ETF0.01%Jul 31, 2026Equity
17DFAXDimensional World ex U.S. Core Equity 2 ETF0.01%Jul 31, 2026Equity
18VSGXVanguard ESG International Stock ETF<0.01%Oct 31, 2026Equity
19VXUSVanguard Total International Stock ETF<0.01%Oct 31, 2026Equity
20VTVanguard Total World Stock Index ETF<0.01%Oct 31, 2026Equity

How we count

Simcere Pharmaceutical Group Ltd (ticker 2096 HKG, listed in HK) is matched in every holdings book ETFIQ publishes, by its ticker and name. A share of the fund is the weight its issuer published, as of the Holdings filed date.

Each row shows the date the fund last filed.

Look up another company.

More

Shares, preferred shares and debt are told by each fund’s N-PORT asset type. A fund holding only the company’s debt or preferred shares is listed under them, not counted as holding its shares. Options, swaps, futures and cash do not count as holding a company: a call option on a share is not the share. Funds whose book is gross exposure, not a portfolio, are left out.

Questions people ask

Which ETFs hold Simcere Pharmaceutical Group Ltd?

20 thematic and core ETFs hold Simcere Pharmaceutical Group Ltd, by holdings dated Jun 30, 2026 to Nov 19, 2026. The largest positions are ECNS at 0.82% of the fund on Nov 19, 2026, AVEE at 0.13% of the fund on Nov 17, 2026 and CXSE at 0.11% of the fund on Jun 30, 2026.

Where these numbers came from

Copy and cite

Cite this pageCitation, APA and Markdown

ETFIQ, ETFs holding Simcere Pharmaceutical Group Ltd, data as of Nov 21, 2026. https://etfiq.com/holdings/simcere-pharmaceutical-group-ltd/

Open data

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.